MELI, Maria
 Distribuzione geografica
Continente #
NA - Nord America 2.316
EU - Europa 1.210
AS - Asia 243
SA - Sud America 7
AF - Africa 2
Totale 3.778
Nazione #
US - Stati Uniti d'America 2.312
IT - Italia 526
CN - Cina 189
UA - Ucraina 161
FI - Finlandia 153
GB - Regno Unito 80
IE - Irlanda 77
DE - Germania 72
SE - Svezia 48
RU - Federazione Russa 27
FR - Francia 19
IN - India 17
KR - Corea 11
BE - Belgio 10
RO - Romania 10
TR - Turchia 9
NL - Olanda 7
IR - Iran 6
BR - Brasile 5
ES - Italia 5
AL - Albania 3
AT - Austria 3
CA - Canada 3
CH - Svizzera 2
CL - Cile 2
GR - Grecia 2
JP - Giappone 2
LB - Libano 2
PL - Polonia 2
UZ - Uzbekistan 2
VN - Vietnam 2
CZ - Repubblica Ceca 1
DZ - Algeria 1
EG - Egitto 1
HK - Hong Kong 1
HR - Croazia 1
LU - Lussemburgo 1
MX - Messico 1
PK - Pakistan 1
TH - Thailandia 1
Totale 3.778
Città #
Fairfield 361
Ashburn 226
Chandler 198
Woodbridge 180
Ann Arbor 154
Seattle 149
Wilmington 142
Houston 140
Cambridge 108
Jacksonville 90
Dublin 77
Palermo 74
Medford 60
Des Moines 48
Nanjing 48
Princeton 39
Altamura 33
Tulsa 24
Beijing 23
Dearborn 23
Milan 23
Boardman 22
Lawrence 21
London 21
Rome 18
Naples 17
Shenyang 16
Ludwigshafen am Rhein 14
Changsha 12
Nanchang 12
San Diego 12
Tianjin 12
Brussels 10
Hebei 10
New York 10
Seongnam 10
Izmir 9
Council Bluffs 8
Jiaxing 8
San Mateo 8
Auburn Hills 7
Saint Petersburg 7
San Paolo di Civitate 7
Turin 7
Verona 7
Zhengzhou 7
Bari 6
Redwood City 6
Bacoli 5
Ningbo 5
Taizhou 5
Torino 5
Washington 5
Carini 4
Corato 4
Florence 4
Jinan 4
Kilburn 4
Los Angeles 4
Paceco 4
Padova 4
Tehran 4
Andover 3
Guangzhou 3
Haikou 3
Longobucco 3
Madison Heights 3
Milazzo 3
Mountain View 3
Napoli 3
Orange 3
Roccadaspide 3
Salamanca 3
Schoenwalde 3
Siena 3
Tappahannock 3
Toronto 3
Turi 3
Afragola 2
Amsterdam 2
Asti 2
Bancali 2
Bologna 2
Campo Calabro 2
Chennai 2
Durham 2
Fisciano 2
Genoa 2
Hanoi 2
Hefei 2
Helsinki 2
Indiana 2
Islington 2
Kunming 2
Lanzhou 2
Lappeenranta 2
Luzzi 2
Monfalcone 2
Monsummano Terme 2
Paris 2
Totale 2.677
Nome #
Heterocyclic and Phenyl Double-Bond-Locked Combretastatin Analogues Possessing Potent Apoptosis-inducing activity in HL60 and in MDR Cell lines 199
Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylation 191
Pterostilbene and 3'-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells 182
Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells with new pimozide derivatives 172
Farmaci antimicrotubulari 144
Histone deacetylase inhibition modulates deoxyribonucleotide pools and enhances the antitumor effects of the ribonucleotide reductase inhibitor 3’-C-methyladenosine in leukaemia cells 142
Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells 137
Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives 135
Expression of the IAPs in multidrug resistant tumor cells 135
NF-kB inhibition restores sensitivity to Fas-mediated apoptosis in lymphoma cell lines 131
The new iodoacetamidobenzofuran derivative TR120 decreases STAT5 expression and induces antitumor effects in imatinib-sensitive and imatinib-resistant BCR-ABL-expressing leukemia cells. 124
The synergistic apoptotic effects of thiophenfurin, an inosine monophosphate dehydrogenase inhibitor, in combination with retinoids in HL60 cells. 123
4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]-pyridines as a new class of cytotoxic Hsp90 inhibitors 119
Effects of Pimozide Derivatives on pSTAT5 in K562 Cells 116
Uso degli inibitori di pompa protonica in un Policlinico Universitario 114
Meccanismi di resistenza ai farmaci antitumorali 109
Farmaci antimicrotubulari. 101
The use of proton pump inhibitors in an Italian hospital: focus on oncologic and critical non-ICU patients 101
From the covalent linkage of drugs to novel inhibitors of ribonucleotide reductase: Synthesis and biological evaluation of valproic esters of 3’-C-methyladenosine 100
Induction of apoptosis by the adenosine derivative IB-MECA in parental or multidrug-resistant HL-60 leukemia cells: possibile relationship to the effects on inhibitor of apoptosis protein levels 95
Farmaci inibitori delle topoisomerasi 95
Resistance to gemcitabine in a lymphoma cell line resistant to Fas-mediated apoptosis 93
Expression of IAPs (Inhibitory of Apoptosis Proteins) and of their alternative splice variants in hepatocellular carcinoma tissues and cells 78
“Effects of combretastatin analogues on leukemic cell lines and normal hemopoietic cells” 77
Hepatotoxicity caused by mebendazole in a patient with Gilbert's syndrome 77
Epigenetic agents as an adjunct to active chemotherapy in hematological tumor cell lines 69
Histone deacetylase (HDAC) inhibitors potentiate the antiproliferative and apoptotic effects induced by the novel ribonucleotide reductase (RR) inhibitor 3'-metil-adenosine (3'-Me-Ado) in promyelocitic leukemia cell lines 67
Antitumor profile of new phenothiazine derivatives. 64
Antitumor effects of novel co-drugs linking histone deacetylase and ribonucleotide reductase inhibitors in hematological tumors 61
Farmacovigilanza attiva sul ruolo dei farmaci antiangiogenetici nell’osteonecrosi dei mascellari 58
Hydroxamic acid-containing histone deacetylase inhibitors potentiate the antiproliferative and apoptotic effects induced by the ribonucleotide reductase R1 inhibitor 3'-C-methyl-adenosine in promyelocytic leukemia cell lines 57
New trends in overcoming drug resistance in hepatocellular carcinoma. Looking for pharmacological inhibition of Inhibitory of Apoptosis Proteins (IAPs) by curcumin. 55
STAT5 and STAT5 Inhibitors in Hematological Malignancies 55
Cytotoxic and apoptotic effects of thiophenfurin in combination with retinoids in human promyelocitic leucemia HL60 cells 53
Histone deacetylase (HDAC) inhibition modulates intracellular deoxynucleotides (dNTP) pools and potentiates the antitumor effects of the ribonucleotide reductase (RR) inhibitor 3’-Methyl-adenosine (3’-Me-Ado) in promyelocitic leukaemia cell lines. 52
Farmaci antimicrotubulari 52
The use of low molecular weight heparin in a Sicilian teaching hospital 45
Meccanismi di resistenza ai farmaci antitumorali. 42
FARMACI INIBITORI DELLE TOPOISOMERASI 39
FARMACI INIBITORI DELLE TOPOISOMERASI 26
FARMACI ANTIMICROTUBULARI 16
MECCANISMI DI RESISTENZA AI FARMACI ANTITUMORALI 10
Totale 3.911
Categoria #
all - tutte 11.593
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.593


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019226 0 0 0 0 0 0 0 0 0 38 85 103
2019/2020945 106 36 54 72 110 123 109 75 106 40 71 43
2020/2021603 24 49 73 41 62 33 79 28 65 40 54 55
2021/2022471 24 106 11 21 13 19 28 30 49 60 26 84
2022/2023614 62 96 5 51 79 91 45 58 75 0 36 16
2023/2024324 27 65 17 27 25 68 49 32 1 13 0 0
Totale 3.911